Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
BeOne Medicines
Acerta Pharma BV
BeiGene
Universität des Saarlandes
Pharmacyclics LLC.
Celgene
Janssen Research & Development, LLC
Eli Lilly and Company
InnoCare Pharma Inc.
University of Giessen
Ruijin Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Oncternal Therapeutics, Inc
Incyte Corporation
Shandong Provincial Hospital
Medical College of Wisconsin
Shandong Provincial Hospital
Gilead Sciences
Universität des Saarlandes
Universität des Saarlandes
Takeda
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Canadian Cancer Trials Group
Celgene
Fred Hutchinson Cancer Center
Swiss Cancer Institute
Takeda
French Innovative Leukemia Organisation
The University of Hong Kong
Teva Branded Pharmaceutical Products R&D, Inc.
Janssen Research & Development, LLC
European Mantle Cell Lymphoma Network
OHSU Knight Cancer Institute
European Mantle Cell Lymphoma Network
Vanderbilt-Ingram Cancer Center
European Mantle Cell Lymphoma Network
Alliance for Clinical Trials in Oncology
Radiation Therapy Oncology Group
Alliance for Clinical Trials in Oncology
University Hospital Heidelberg
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)